Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.
Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.
Caryn Lerman Recruited By Univ. Of Pennsylvania.
BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.
FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.
Impath Buys Clinical Studies Support Services Network.
MGI Pharma, MethylGene Begin Phase II Trial Of MG98.
Vasopermeation Technology Awarded Patent For CA Firm.
FDA Approves Xeloda For Breast Cancer Treatment.
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills
